Sign in
4

Changes in Ownership

INSMED Inc Filed Acc 0001628280-25-021897

Chair and CEO sold 6,830 shares at an average $72.57 ($495,668)

  • Chair and CEO acquired 6,830 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lewis William · Chair and CEO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-05-01 Exercise or conversion : show line 1 in the form 10b5-1 +6,830 $10.85 $74,106 240,754 I
2025-05-01 Sale : show line 2 in the form 10b5-1 −2,629 $72.24 $189,919 238,125 I
2025-05-01 Sale : show line 3 in the form 10b5-1 −4,201 $72.78 $305,749 233,924 I
Open-market sales · 6,830 sh · avg $72.57 · $495,668

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-01 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) −6,830 170,820 I
Loading xslF345X05/wk-form4_1746218581.xml…